139 related articles for article (PubMed ID: 37552341)
41.
Petrik M; Umlaufova E; Raclavsky V; Palyzova A; Havlicek V; Pfister J; Mair C; Novy Z; Popper M; Hajduch M; Decristoforo C
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):372-382. PubMed ID: 32734456
[TBL] [Abstract][Full Text] [Related]
42. Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with
Patrick PS; Kolluri KK; Zaw Thin M; Edwards A; Sage EK; Sanderson T; Weil BD; Dickson JC; Lythgoe MF; Lowdell M; Janes SM; Kalber TL
Stem Cell Res Ther; 2020 Jun; 11(1):256. PubMed ID: 32586403
[TBL] [Abstract][Full Text] [Related]
43. CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging.
Ulaner GA; Sobol NB; O'Donoghue JA; Kirov AS; Riedl CC; Min R; Smith E; Carter LM; Lyashchenko SK; Lewis JS; Landgren CO
Radiology; 2020 Jun; 295(3):606-615. PubMed ID: 32255416
[TBL] [Abstract][Full Text] [Related]
44. In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody-Drug Conjugates: Taking Advantage of Dual Labeling with
Muns JA; Montserrat V; Houthoff HJ; Codée-van der Schilden K; Zwaagstra O; Sijbrandi NJ; Merkul E; van Dongen GAMS
J Nucl Med; 2018 Jul; 59(7):1146-1151. PubMed ID: 29496986
[TBL] [Abstract][Full Text] [Related]
45. Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®.
Liapis V; Tieu W; Rudd SE; Donnelly PS; Wittwer NL; Brown MP; Staudacher AH
EJNMMI Radiopharm Chem; 2020 Nov; 5(1):27. PubMed ID: 33205364
[TBL] [Abstract][Full Text] [Related]
46.
Verhoeff SR; van de Donk PP; Aarntzen EHJG; Oosting SF; Brouwers AH; Miedema IHC; Voortman J; Menke-van der Houven van Oordt WC; Boellaard R; Vriens D; Slingerland M; Hermsen R; Grunsven IVE; Heskamp S; van Herpen CML
J Nucl Med; 2022 Oct; 63(10):1523-1530. PubMed ID: 35512998
[TBL] [Abstract][Full Text] [Related]
47. Cyclic versus Noncyclic Chelating Scaffold for
Summer D; Garousi J; Oroujeni M; Mitran B; Andersson KG; Vorobyeva A; Löfblom J; Orlova A; Tolmachev V; Decristoforo C
Mol Pharm; 2018 Jan; 15(1):175-185. PubMed ID: 29160082
[TBL] [Abstract][Full Text] [Related]
48. Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer.
Vázquez SM; Endepols H; Fischer T; Tawadros SG; Hohberg M; Zimmermanns B; Dietlein F; Neumaier B; Drzezga A; Dietlein M; Schomäcker K
Mol Imaging Biol; 2022 Feb; 24(1):115-125. PubMed ID: 34370181
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and preclinical evaluation of a
Pringle TA; Ramon-Gil E; Leslie J; Oakley F; Wright MC; Knight JC; Luli S
Sci Rep; 2024 Jan; 14(1):633. PubMed ID: 38182623
[TBL] [Abstract][Full Text] [Related]
50. [(89)Zr]oxinate4 for long-term in vivo cell tracking by positron emission tomography.
Charoenphun P; Meszaros LK; Chuamsaamarkkee K; Sharif-Paghaleh E; Ballinger JR; Ferris TJ; Went MJ; Mullen GE; Blower PJ
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):278-87. PubMed ID: 25359636
[TBL] [Abstract][Full Text] [Related]
51. Construction and preclinical evaluation of a zirconium-89 labelled monoclonal antibody targeting PD-L2 in lung cancer.
Yao Y; Ren Y; Hou X; Zhu J; Ma X; Liu S; Liu T; Zhang Q; Ma X; Yang Z; Zhu H; Li N
Biomed Pharmacother; 2023 Dec; 168():115602. PubMed ID: 37852097
[TBL] [Abstract][Full Text] [Related]
52. Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging.
Novy Z; Janousek J; Barta P; Petrik M; Hajduch M; Trejtnar F
J Labelled Comp Radiopharm; 2021 Jun; 64(7):262-270. PubMed ID: 33818828
[TBL] [Abstract][Full Text] [Related]
53. PET Imaging of Liposomal Glucocorticoids using
Gawne PJ; Clarke F; Turjeman K; Cope AP; Long NJ; Barenholz Y; Terry SYA; de Rosales RTM
Theranostics; 2020; 10(9):3867-3879. PubMed ID: 32226525
[TBL] [Abstract][Full Text] [Related]
54.
Benedetto R; Massicano AVF; Crenshaw BK; Oliveira R; Reis RM; Araújo EB; Lapi SE
Cancer Biother Radiopharm; 2019 Jun; 34(5):288-296. PubMed ID: 30865493
[No Abstract] [Full Text] [Related]
55. Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice.
Waaijer SJH; Suurs FV; Hau CS; Vrijland K; de Visser KE; de Groot DJA; de Vries EGE; Lub-de Hooge MN; Schröder CP
Front Oncol; 2021; 11():786191. PubMed ID: 34976826
[TBL] [Abstract][Full Text] [Related]
56. Preclinical Evaluation of
Moisio O; Virta J; Yatkin E; Liljenbäck H; Palani S; Viitanen R; Miner MWG; Oikonen V; Tolvanen T; Vugts DJ; Taimen P; Li XG; Hollmén M; Jalkanen S; Roivainen A
J Nucl Med; 2023 Apr; 64(4):555-560. PubMed ID: 36302655
[TBL] [Abstract][Full Text] [Related]
57. Toward Optimized
Damerow H; Cheng X; von Kiedrowski V; Schirrmacher R; Wängler B; Fricker G; Wängler C
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297549
[TBL] [Abstract][Full Text] [Related]
58. An
Dietlein F; Kobe C; Vázquez SM; Fischer T; Endepols H; Hohberg M; Reifegerst M; Neumaier B; Schomäcker K; Drzezga AE; Dietlein M
J Nucl Med; 2022 Apr; 63(4):573-583. PubMed ID: 34326129
[TBL] [Abstract][Full Text] [Related]
59. Manganese-52: applications in cell radiolabelling and liposomal nanomedicine PET imaging using oxine (8-hydroxyquinoline) as an ionophore.
Gawne P; Man F; Fonslet J; Radia R; Bordoloi J; Cleveland M; Jimenez-Royo P; Gabizon A; Blower PJ; Long N; de Rosales RTM
Dalton Trans; 2018 Jul; 47(28):9283-9293. PubMed ID: 29796500
[TBL] [Abstract][Full Text] [Related]
60.
Roy J; Jagoda EM; Basuli F; Vasalatiy O; Phelps TE; Wong K; Ton AT; Hagemann UB; Cuthbertson AS; Cole PE; Hassan R; Choyke PL; Lin FI
Cancer Biother Radiopharm; 2021 May; 36(4):316-325. PubMed ID: 34014767
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]